Atlas Trials

The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune Hepatitis

Clinical trial NCT02050646 · COMPLETED

Trial details

NCT number
NCT02050646
Sponsor
Yale University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Autoimmune Hepatitis
Start date
2013-08-27
Primary completion
2019-08-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.